GC
NEO icon

Grace Capital’s NeoGenomics NEO Stock Holding History

Grace Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$850K Buy
24,900
+15,800
+174% +$619K 0.5% 56
2021
Q3 		$413K Buy
9,100
+2,800
+44% +$130K 0.25% 106
2021
Q2 		$285K Sell
6,300
-3,000
-32% -$133K 0.19% 114
2021
Q1 		$449K Hold
9,300
– – 0.29% 96
2020
Q4 		$501K Buy
9,300
+3,300
+55% +$149K 0.32% 89
2020
Q3 		$221K Buy
6,000
+4,000
+200% +$149K 0.17% 118
2020
Q2 		$62K Buy
+2,000
New +$55.4K 0.05% 174

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grace Capital's NEO Position: Q4 2021 in Review

Grace Capital increased its NeoGenomics (NEO) stake by 174% in Q4 2021, buying an estimated $619K and bringing the position to 24,900 shares worth $850K. The position accounts for 0.5% of the portfolio, ranked #56.

Grace Capital first reported a position in NEO in Q2 2020 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Grace Capital held 24,900 shares of NeoGenomics worth $850K as of Q4 2021.
  • Grace Capital bought 15,800 NeoGenomics shares in Q4 2021, an estimated $619K.
  • NeoGenomics made up 0.5% of Grace Capital's portfolio in Q4 2021, its #56 holding.
  • Grace Capital first reported a position in NeoGenomics in Q2 2020 and has held it in 7 quarters since.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.